Predict your next investment

Corporation
HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research
synlab.com

See what CB Insights has to offer

Founded Year

1998

Stage

IPO | IPO

Total Raised

$265M

Date of IPO

4/28/2021

Revenue

$0000 

About SYNLAB

SYNLAB is a provider of medical laboratory services for practicing doctors, clinics, and the pharmaceutical industry in Europe. The company offers a full range of laboratory analysis for human and veterinary medicine as well as the environment. In addition to Germany, it has branches in other European countries as well as Turkey, Saudi Arabia, and Dubai.

SYNLAB Headquarter Location

Moosacher Strasse 88

Munich, 80809,

Germany

+49 89 307602-0

Latest SYNLAB News

Spain: Synlab strengthens genetics offering with acquisition of Sistemas Genómicos in Spain

Jan 11, 2022

LaingBuisson News Home Healthcare Markets International News Spain: Synlab strengthens genetics offering with acquisition of Sistemas Genómicos in Spain By Synlab, Europe’s largest clinical laboratory and medical diagnostic services company, has kicked off its planned €200m (US$226.6m) 2022 M&A spend with the acquisition of Sistemas Genómicos of the Ascires Group in Spain, further strengthening its genetics offering. Sistemas Genómicos, a laboratory specialised in genetics and bioinformatics, will strategically complement Synlab’s capabilities in genetics and accelerate… You must be a HMI Subscriber to view this content. Login » Nick Herbert has over 30 years’ experience in the financial markets, as both a practitioner and journalist. He started work as an investment banker in London, before joining International Financing Review (IFR) to report on debt capital markets and derivatives. He moved to Singapore in 2000 to manage IFR’s financial markets editorial team throughout Asia, before returning to London in 2009 to take up the position of Publisher for Reuters Capital Markets Publications. For the last five years he has been covering global capital markets, ESG finance and healthcare markets on a freelance basis.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

SYNLAB Patents

SYNLAB has filed 2 patents.

The 3 most popular patent topics include:

  • Calcium channel blockers
  • Kidney diseases
  • Medical terminology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/23/2019

Kidney diseases, Nephrology, Calcium channel blockers, Syndromes, Medical terminology

Application

Application Date

7/23/2019

Grant Date

Title

Related Topics

Kidney diseases, Nephrology, Calcium channel blockers, Syndromes, Medical terminology

Status

Application

SYNLAB Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

SYNLAB Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.